Eyeworld Supplements

ASCRS Clinical Survey 2013

This is a supplement to EyeWorld Magazine.

Issue link: https://supplements.eyeworld.org/i/203235

Contents of this Issue

Navigation

Page 7 of 7

Glaucoma/Retina The survey data shows about half of all prostaglandin analog prescriptions per year are performed by ASCRS members, as these represent about 62% of all their patients. Yet less than one-third of patients are believed to be regularly compliant with their prostaglandin therapies. While many factors are involved, generally 23-26 mm Hg are the levels upon which respondents believe a combined glaucoma/cataract procedure is warranted, which is about 10% of all procedures. About one-quarter of cataract patients are currently being co-managed for AMD or DME, however about one-third of respondents do not agree that they have an in-depth understanding of anti-VEGF therapies and their impact. Interestingly, about 40% of respondents claim to be performing some volume of intravitreal injections themselves, instead of referring it to a retinal specialist, however only half of these doctors are doing this the majority of the time. 8

Articles in this issue

Archives of this issue

view archives of Eyeworld Supplements - ASCRS Clinical Survey 2013